Showing results (721-730 of 830) with videos related to

Sort By:
Pageof 83
Journal of Lipid Research|February 16, 2020
Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart StudyGemma Cadby, Phillip E Melton, Nina S McCarthy, et al.
European Heart Journal|November 17, 2021
Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysisClara Marquina, Paul Lacaze, Jane Tiller, et al.
Journal of the American College of Cardiology|September 29, 2022
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) GenotypesPaul Lacaze, Andrew Bakshi, Moeen Riaz, et al.
BMC Cardiovascular Disorders|March 10, 2022
Common genetic variants do not predict recurrent events in coronary heart disease patientsP L Thompson, J Hui, J Beilby, et al.
Current Vascular Pharmacology|May 8, 2019
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main TextGenovefa D Kolovou, Gerald F Watts, Dimitri P Mikhailidis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRsA Melián, G F Watts, A Shamshiev, et al.
Clinical Endocrinology|December 14, 2005
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?T W K Ng, G F Watts, B G A Stuckey, et al.
Thrombosis and Haemostasis|May 29, 2015
Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trialsAmirhossein Sahebkar, Corina Serban, Dimitri P Mikhailidis, et al.
Journal of Clinical Lipidology|June 3, 2017
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugsClaudia Stefanutti, Ulrich Julius, Gerald F Watts, et al.
Pageof 83